Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Roth

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug designBrian N Cook, Jörg Bentzien, Andre White, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Imidazole-derived agonists for the neurotensin 1 receptorPaul M Hershberger, Michael P Hedrick, Satyamaheshwar Peddibhotla, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitorsRoger J Snow, Asitha Abeywardane, Scot Campbell, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole leadKevin J Moriarty, Michael Winters, Lei Qiao, et al.
ACS Medicinal Chemistry Letters|October 18, 2011
Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB ActivationPasha M Khan, Ricardo G Correa, Daniela B Divlianska, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)Michael P Winters, Darius J Robinson, Hnin Hnin Khine, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptorPatrick R Maloney, Pasha Khan, Michael Hedrick, et al.
Journal of Medicinal Chemistry|July 21, 2012
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitroJanina Preuss, Patrick Maloney, Satyamaheshwar Peddibhotla, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)Kevin J Moriarty, Hidenori Takahashi, Steven S Pullen, et al.
Journal of Biomolecular Screening|May 30, 2014
Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family ProteinsChristian A Hassig, Fu-Yue Zeng, Paul Kung, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug designBrian N Cook, Jörg Bentzien, Andre White, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Imidazole-derived agonists for the neurotensin 1 receptorPaul M Hershberger, Michael P Hedrick, Satyamaheshwar Peddibhotla, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitorsRoger J Snow, Asitha Abeywardane, Scot Campbell, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole leadKevin J Moriarty, Michael Winters, Lei Qiao, et al.
ACS Medicinal Chemistry Letters|October 18, 2011
Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB ActivationPasha M Khan, Ricardo G Correa, Daniela B Divlianska, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)Michael P Winters, Darius J Robinson, Hnin Hnin Khine, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptorPatrick R Maloney, Pasha Khan, Michael Hedrick, et al.
Journal of Medicinal Chemistry|July 21, 2012
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitroJanina Preuss, Patrick Maloney, Satyamaheshwar Peddibhotla, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)Kevin J Moriarty, Hidenori Takahashi, Steven S Pullen, et al.
Journal of Biomolecular Screening|May 30, 2014
Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family ProteinsChristian A Hassig, Fu-Yue Zeng, Paul Kung, et al.
Pageof 4